Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GALAXY: Simeprevir and Sofosbuvir in Recurrent HCV Genotype 1 Post-Liver Transplant
NCT02165189Phase 2Completed
- Sponsor
- Janssen Scientific Affairs
- Start
- Aug 2014
- Primary completion
- Nov 2015
- Modality
- Reversible Covalent Inhibitors, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of simeprevir in hepatitis C (HCV), sponsored by Janssen Scientific Affairs. Started Aug 2014; status: completed.
02
Drugs
simeprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02165189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02165189.